Philippe Fauchet
Director/Board Member at REZOLUTE, INC.
Net worth: - $ as of 2024-03-30
Profile
Philippe Fauchet is currently an Outside Director at JCR Pharmaceuticals Co., Ltd., an Independent Director at Rezolute, Inc., an Independent Outside Director at Noile-Immune Biotech, Inc., an Outside Director at Luca Science, Inc., and a Venture Partner & Japana6 at 4BIO Ventures Management Ltd.
Previously, he was the Chairman at GlaxoSmithKline KK from 2018 to 2019 and held a Vice President-Corporate Business Development position at Sanofi-Aventis Groupe SA. He graduated from École des Hautes Études Commerciales de Paris with a graduate degree and from Université Paris Nanterre with an undergraduate degree.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REZOLUTE, INC.
-.--% | 2024-01-22 | 0 ( -.--% ) | - $ | 2024-03-30 |
Philippe Fauchet active positions
| Companies | Position | Start |
|---|---|---|
| REZOLUTE, INC. | Director/Board Member | 2020-09-09 |
| NOILE-IMMUNE BIOTECH INC. | Director/Board Member | 2020-02-29 |
| JCR PHARMACEUTICALS CO., LTD. | Director/Board Member | - |
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Private Equity Investor | 2018-12-31 |
Luca Science, Inc.
 Luca Science, Inc. BiotechnologyHealth Technology Luca Science, Inc. is a Japanese preclinical stage biopharmaceutical company that specializes in mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tissues and organs. Luca Science is based in Chuo-ku, JP, and was founded in December 2018 by Masashi Suganuma. The company uses its platform technology to manufacture, store, and deliver innovative mitochondrial drugs to research and develop therapeutics for unmet medical needs in a wide range of diseases for which there have been no effective treatments. The CEO is Rick C. Tsai. | Director/Board Member | 2022-05-31 |
Former positions of Philippe Fauchet
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | President | 2018-01-12 |
Sanofi-Aventis Groupe SA
 Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Training of Philippe Fauchet
| École des Hautes Études Commerciales de Paris | Graduate Degree |
| Université Paris Nanterre | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| JCR PHARMACEUTICALS CO., LTD. | Health Technology |
| REZOLUTE, INC. | Health Technology |
| NOILE-IMMUNE BIOTECH INC. | Health Technology |
| Private companies | 4 |
|---|---|
GlaxoSmithKline KK
GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Consumer Non-Durables |
Sanofi-Aventis Groupe SA
Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Finance |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Finance |
Luca Science, Inc.
Luca Science, Inc. BiotechnologyHealth Technology Luca Science, Inc. is a Japanese preclinical stage biopharmaceutical company that specializes in mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tissues and organs. Luca Science is based in Chuo-ku, JP, and was founded in December 2018 by Masashi Suganuma. The company uses its platform technology to manufacture, store, and deliver innovative mitochondrial drugs to research and develop therapeutics for unmet medical needs in a wide range of diseases for which there have been no effective treatments. The CEO is Rick C. Tsai. | Health Technology |
- Stock Market
- Insiders
- Philippe Fauchet
